Müllerian inhibiting substance recruits ALK3 to regulate Leydig cell differentiation

Endocrinology

Volumn 153, Issue 10, 2012, Pages 4929-4937

  Wu, Xiufeng ^a   Zhang, Ningning ^a   Lee, Mary M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3ALPHA HYDROXYSTEROID DEHYDROGENASE; 3BETA HYDROXY DELTA5 STEROID DEHYDROGENASE; 3BETA HYDROXY DELTA5 STEROID DEHYDROGENASE III; 3BETA HYDROXY DELTA5 STEROID DEHYDROGENASE VI; ANDROSTENEDIONE; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; CRE RECOMBINASE; CYCLINE; CYTOCHROME P450 17; HORMONE RECEPTOR; MESSENGER RNA; MUELLERIAN INHIBITING FACTOR; MUELLERIAN INHIBITING FACTOR RECEPTOR 3; STEROID 5ALPHA REDUCTASE 2; STEROIDOGENIC ACUTE REGULATORY PROTEIN; TESTOSTERONE; UNCLASSIFIED DRUG; ACTIVIN RECEPTOR 1; ACVR1 PROTEIN, MOUSE; ANTI MULLERIAN HORMONE RECEPTOR; ANTI-MULLERIAN HORMONE RECEPTOR; BMPR1A PROTEIN, MOUSE; BMPR1B PROTEIN, MOUSE; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; LUTEINIZING HORMONE; PHOSPHOPROTEIN; RECEPTOR; STEROID 17ALPHA MONOOXYGENASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANDROSTENEDIONE BLOOD LEVEL; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; DOWN REGULATION; GENE EXPRESSION; GENETIC CODE; KNOCKOUT MOUSE; LEYDIG CELL; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STEROIDOGENESIS; TESTOSTERONE BLOOD LEVEL; ANIMAL; BLOOD; CELL COUNT; CYTOLOGY; GENETICS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; TESTIS;

ACTIVIN RECEPTORS, TYPE I; ANDROSTENEDIONE; ANIMALS; ANTI-MULLERIAN HORMONE; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; CELL COUNT; CELL DIFFERENTIATION; DOWN-REGULATION; LEYDIG CELLS; LUTEINIZING HORMONE; MALE; MICE; MICE, KNOCKOUT; PHOSPHOPROTEINS; RECEPTORS, PEPTIDE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; STEROID 17-ALPHA-HYDROXYLASE; TESTIS; TESTOSTERONE;

EID: 84866753927     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1168     Document Type: Article

References (48)

1. Massagué J 1998 TGF-β signal transduction. Annu Rev Biochem 67:753-791
2. Massagué J, Wotton D 2000 Transcriptional control by the TGFbeta/ Smad signaling system. EMBo J 19:1745-1754 (Pubitemid 30204386)
3. Behringer RR, Cate RL, Froelick GJ, Palmiter RD, Brinster RL 1990 Abnormal sexual development in transgenic mice chronically expressing mullerian inhibiting substance. Nature 345:167-170
4. Behringer RR, Finegold MJ, Cate RL 1994 Mullerian-inhibiting substance function during mammalian sexual development. Cell 79:415-425
5. Lee MM 2000 MIS actions in the developing testis. In: Goldberg E, ed. The testis: from stem cell to sperm function. New York: Springer-Verlag; 30-42
6. Lee MM, Seah CC, Masiakos PT, Sottas CM, Preffer FI, Donahoe PK, Maclaughlin DT, Hardy MP 1999 Mullerian inhibiting substance type II receptor expression and function in purified rat Leydig cells. Endocrinology 140:2819-2827 (Pubitemid 32245162)
7. Racine C, Rey R, Forest MG, Louis F, Ferré A, Huhtaniemi I, Josso N, di Clemente N 1998 Receptors for anti-Mullerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation. Proc Natl Acad Sci USA 95:594-599
8. Salva A, Hardy MP, Wu XF, Sottas CM, MacLaughlin DT, Donahoe PK, Lee MM 2004 Mullerian-inhibiting substance inhibits rat Leydig cell regeneration after ethylene dimethanesulphonate ablation. Biol Reprod 70:600-607 (Pubitemid 38233696)
9. Wu X, Arumugam R, Baker SP, Lee MM 2005 Pubertal and adult Leydig cell function in Mullerian inhibiting substance-deficient mice. Endocrinology 146:589-595 (Pubitemid 40129814)
10. Kretzschmar M, Massagué J 1998 SMADs: mediators and regulators of TGF-α signaling. Curr Opin Genet Dev 8:103-111 (Pubitemid 28122148)
11. Clarke TR, Hoshiya Y, Yi SE, Liu X, Lyons KM, Donahoe PK 2001 Mullerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression. Mol Endocrinol 15:946-959 (Pubitemid 32510641)
12. Gouédard L, Chen YG, Thevenet L, Racine C, Borie S, Lamarre I, Josso N, Massagué J, di Clemente N 2000 Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Mullerian hormone and its type II receptor. J Biol Chem 275:27973-27978
13. Visser JA, Olaso R, Verhoef-Post M, Kramer P, Themmen AP, Ingraham HA 2001 The serine/threonine transmembrane receptor ALK2 mediates Mullerian inhibiting substance signaling. Mol Endocrinol 15:936-945 (Pubitemid 32510640)
14. Matzuk MM, Finegold MJ, Mishina Y, Bradley A, Behringer RR 1995 Synergistic effects of inhibins and Mullerian-inhibiting substance on testicular tumorigenesis. Mol Endocrinol 9:1337-1345
15. Mishina Y 2002 The in vivo function of Mullerian-inhibiting substance during mammalian sexual development. In: Matzuk MM, Brown CW, Kumar TR, eds. Transgenics in endocrinology (contemporary endocrinology). Totowa, NJ: Human Press; 41-59
16. Mishina Y, Crombie R, Bradley A, Behringer RR 1999 Multiple roles for activin-like kinase-2 signaling during mouse embryogenesis. Dev Biol 213:314-326 (Pubitemid 29444342)
17. Mishina Y, Rey R, Finegold MJ, Matzuk MM, Josso N, Cate RL, Behringer RR 1996 Genetic analysis of the Mullerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev 10:2577-2587 (Pubitemid 26357224)
18. Lyet L, Louis F, Forest MG, Josso N, Behringer RR, Vigier B 1995 Ontogeny of reproductive abnormalities induced by deregulation of anti-Mullerian hormone expression in transgenic mice. Biol Reprod 52:444-454
19. Gu Z, Reynolds EM, Song J, Lei H, Feijen A, Yu L, He W, MacLaughlin DT, van den Eijnden-van Raaij J, Donahoe PK, Li E 1999 The type I serine/threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryo. Development 126:2551-2561 (Pubitemid 29299023)
20. Mishina Y, Suzuki A, Ueno N, Behringer RR 1995 Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev 9:3027-3037 (Pubitemid 26018138)
21. Mishina Y, Whitworth DJ, Racine C, Behringer RR 1999 High specificity of Mullerian-inhibiting substance signaling in vivo. Endocrinology 140:2084-2088 (Pubitemid 30636446)
22. Jamin SP, Arango NA, Mishina Y, Behringer RR 2002 Genetic studies of MIS signalling in sexual development. Novartis Found Symp 244:157-164, discussion 164-168, 203-206, 253-257
23. Jamin SP, Arango NA, Mishina Y, Hanks MC, Behringer RR 2002 Requirement of Bmpr1a for Mullerian duct regression during male sexual development. Nat Genet 32:408-410 (Pubitemid 35266116)
24. Jamin SP, Arango NA, Mishina Y, Hanks MC, Behringer RR 2003 Genetic studies of the AMH/MIS signaling pathway for Mullerian duct regression. Mol Cell Endocrinol 211:15-19 (Pubitemid 37491230)
25. Belville C, Jamin SP, Picard JY, Josso N, di Clemente N 2005 Role of type I receptors for anti-Mullerian hormone in the SMAT-1 Sertoli cell line. Oncogene 24:4984-4992 (Pubitemid 41129102)
26. Aoki H, Fujii M, Imamura T, Yagi K, Takehara K, Kato M, Miyazono K 2001 Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. J Cell Sci 114:1483-1489 (Pubitemid 32427835)
27. Bernard DJ 2003 SMAD expression in the testis predicts age- and cell-specific responses to activin and TGFβ. J Androl 24:201-203
28. Xu J, Beyer AR, Walker WH, McGee EA 2003 Developmental and stage-specific expression of Smad2 and Smad3 in rat testis. J Androl 24:192-200
29. Yoon BS, Ovchinnikov DA, Yoshii I, Mishina Y, Behringer RR, Lyons KM 2005 Bmpr1a and Bmpr1b have overlapping functions and are essential for chondrogenesis in vivo. Proc Natl Acad Sci USA 102:5062-5067
30. Klinefelter GR, Hall PF, Ewing LL 1987 Effect of luteinizing hormone deprivation in situ on steroidogenesis of rat Leydig cells purified by a multistep procedure. Biol Reprod 36:769-783
31. Klinefelter GR, Kelce WR, Hardy MP 1993 Isolation and culture of Leydig cells from adult rats. In: Heindel J, Chaplin RE, eds. Methods in reproductive toxicology. New York: Academic Press; 166-181
32. Salva A, Klinefelter GR, Hardy MP 2001 Purification of rat Leydig cells: increased yields after unit-gravity sedimentation of collagenase- dispersed interstitial cells. J Androl 22:665-671 (Pubitemid 32623086)
33. Payne AH, Downing JR, Wong KL 1980 Luteinizing hormone receptors and testosterone synthesis in two distinct populations of Leydig cells. Endocrinology 106:1424-1429 (Pubitemid 10094440)
34. Wang ZJ, Jeffs B, Ito M, Achermann JC, Yu RN, Hales DB, Jameson JL 2001 Aromatase (Cyp19) expression is up-regulated by targeted disruption of Dax1. Proc Natl Acad Sci USA 98:7988-7993 (Pubitemid 32642674)
35. Cochran RC, Ewing LL, Niswender GD 1981 Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5α-dihydrotestosterone, 5α-androstane-3α,17β-diol, 5α-androstane-3β,17β-diol, and 17β-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia. Invest Urol 19:142-147 (Pubitemid 12236414)
36. Cochran RC, Schuetz AW, Ewing LL 1979 Age-related changes in conversion of 5α-androstan-17β-ol-3-one to 5α-androstane- 3α,17β-diol and 5α-androstane-3β,17β-diol by rat testicular cells in vitro. J Reprod Fertil 57:143-147
37. Coffey JC, French FS, Nayfeh SN 1971 Metabolism of progesterone by rat testicular homogenates. IV. Further studies of testosterone formation in immature testis in vitro. Endocrinology 89:865-872
38. Weinstein A, Lindner HR, Friedlander A, Bauminger S 1972 Antigenic complexes of steroid hormones formed by coupling to protein through position 7: preparation from 4-3-oxosteroids and characterization of antibodies to testosterone and androstenedione. Steroids 20:789-812
39. Zamecnik J, Barbe G, Moger WH, Armstrong DT 1977 Radioim- munoassays for androsterone, 5α-androstane-3α,17β-diol and 5α- androstane-3β,17β-diol. Steroids 30:679-689 (Pubitemid 8315099)
40. O'Shaughnessy PJ, Johnston H, Willerton L, Baker PJ 2002 Failure of normal adult Leydig cell development in androgen-receptor-deficient mice. J Cell Sci 115:3491-3496 (Pubitemid 34994038)
41. O'Shaughnessy PJ, Willerton L, Baker PJ 2002 Changes in Leydig cell gene expression during development in the mouse. Biol Reprod 66:966-975 (Pubitemid 34263116)
42. Dong L, Jelinsky SA, Finger JN, Johnston DS, Kopf GS, Sottas CM, Hardy MP, Ge RS 2007 Gene expression during development of fetal and adult Leydig cells. Ann NY Acad Sci 1120:16-35
43. Ge RS, Hardy MP 1998 Variation in the end products of androgen biosynthesis and metabolism during postnatal differentiation of rat Leydig cells. Endocrinology 139:3787-3795 (Pubitemid 28512259)
44. Wu X, Arumugam R, Zhang N, Lee MM 2010 Androgen profiles during pubertal Leydig cell development in mice. Reproduction 140: 113-121
45. Sriraman V, Niu E, Matias JR, Donahoe PK, MacLaughlin DT, Hardy MP, Lee MM 2001 Mullerian inhibiting substance inhibits testosterone synthesis in adult rats. J Androl 22:750-758 (Pubitemid 32781262)
46. Wu X, Wan S, Lee MM 2007 Key factors in the regulation of fetal and postnatal Leydig cell development. J Cell Physiol 213:429-433 (Pubitemid 47509723)
47. Ge RS, Shan LX, Hardy MP 1996 Pubertal development of Leydig cells. In: Payne AH, Hardy MP, Russell LD, eds. The Leydig cell. 1st ed. Vienna, Cache River Press; 159-174
48. Hardy MP, Gelber SJ, Zhou ZF, Penning TM, Ricigliano JW, Ganjam VK, Nonneman D, Ewing LL 1991 Hormonal control of Leydig cell differentiation. Ann NY Acad Sci 637:152-163